Cochlear Limited (ASX: COH)
Health Care · Health Care Equipment & Supplies · AU
AU$128.39
-0.47% today · -54.5% 1Y
Cochlear Limited (ASX: COH) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $5.86B and employs 5,400 people.
Over the last twelve months the share price has lost 54.5%, trading between 88.74 and 296.50.
Tweenvest scores Cochlear Limited across four factors: quality 85/100, value 77/100, growth 34/100, dividend 35/100. Its strongest factor is quality.
COH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.86B
- Revenue (TTM)
- $1.62B
- P/E
- 57.11
- EPS
- 2.25
- Dividend yield
- 2.02%
- Beta (5Y)
- 0.24
- 52-week high
- AU$296.50
- 52-week low
- AU$88.74
- Avg volume (3M)
- —
- Shares outstanding
- 65.40M
- Employees
- 5,400
- Next earnings
- —
About Cochlear Limited
Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
- ISIN
- AU000000COH5
- Founded
- 1981
- Listed since
- Dec 31, 1995
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Getinge AB (publ)OM: GETI B | $6.90B | Skr253.20 | +2.76% |
| Lantheus Holdings, Inc.NasdaqGM: LNTH | $6.54B | $100.15 | +0.03% |
| Bausch + Lomb CorporationNYSE: BLCO | $6.18B | $16.85 | -2.63% |
| Shenzhen New Industries Biomedical Engineering Co., Ltd.SZSE: 300832 | $5.92B | CN¥50.50 | +3.31% |
| Ypsomed Holding AGSWX: YPSN | $5.73B | CHF359.60 | -0.72% |
| Convatec Group PLCLSE: CTEC | $5.69B | £2.28 | +3.73% |
| Asahi Intecc Co., Ltd.TSE: 7747 | $5.64B | ¥3,363.00 | -0.33% |
| MiniMed Group, Inc.NasdaqGS: MMED | $5.55B | $18.87 | -4.26% |
Figures last refreshed Oct 11, 2026.